HELP     Sign In
Search

Relevance to Autism

Although Nrg1(+/-) mice have been used as a model for schizophrenia, the decrease in social activity observed in these mice in Ehrlichman et al., 2009 mimic the social deficits observed in autistic patients.

Molecular Function

The protein encoded by this gene is a membrane glycoprotein that that mediates cell-cell signaling and plays a critical role in the growth and development of multiple organ systems. Dysregulation of this gene has been linked to diseases such as schizophrenia and bipolar disorder (BPD).

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions.
Support
Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia.
Highly Cited
Association of neuregulin 1 with schizophrenia confirmed in a Scottish population.
Highly Cited
Neuregulin 1 and susceptibility to schizophrenia.

Rare

No Rare Variants Available

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
8
Deletion-Duplication
 14
 
8
Deletion-Duplication
 2
 
8
Duplication
 1
 
8
Deletion
 2
 
8
Duplication
 1
 
8
Duplication
 1
 
8
Duplication
 1
 
8
Duplication
 5
 
8
Duplication
 3
 
8
Duplication
 5
 
8
Duplication
 1
 
8
Duplication
 1
 

Model Summary

Mice had impairments in a subset of behavioral and electrophysiological tasks relevant to the negative/cognitive symptom domains of schizophrenia that are thought to be influenced by glutamatergic and dopaminergic neurotransmission.

References

Type
Title
Author, Year
Primary
Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions.

M_NRG1_1_KO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Exon 6 of Nrg1 gene is fused to beta-galactosidase which results in deletion of EGF like domains of all 3 major types of Nrg1.
Allele Type: Targeted (Knock Out)
Strain of Origin: Not specified
Genetic Background: C57BL/6/129
ES Cell Line: Not specified
Mutant ES Cell Line: Not Specified
Model Source: Not Specified

M_NRG1_1_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Event related potential (erp) in electroencephalography (eeg)1
Decreased
Description: Decreased mismatch negativity in response to novel stimuli as demonstrated by a positive difference wave from 50-100 ms
Exp Paradigm: Erp recording of novelty task
 Event related potential (erp)
 Unreported
Startle response: acoustic stimulus1
Decreased
Description: Decreased acoustic startle response after treatment with amphetamine
Exp Paradigm: Measurement of startle response in response to acoustic stimuli delivered by a white noise generator after treatment with amphetamines
 Acoustic startle reflex test
 14-22 weeks
Sensorimotor gating1
Decreased
Description: Decreased pre-pulse inhibition to acoustic stimuli after treatment with amphetamine
Exp Paradigm: Measurement of inhibition of startle response after presentation of a non-startling pre-pulse after amphetamine treatment
 Prepulse inhibition
 14-22 weeks
Social interaction1
Decreased
Description: Decreased social interaction demonstrated by lower levels of approach toward stimulus mice and direct sniffing
Exp Paradigm: Social approach test in three chambered apparatus
 Three-chamber social approach test
 Unreported
Cued or contextual fear conditioning: memory of context1
Decreased
Description: Decreased contextual fear conditioning indicated by reduction in freezing
Exp Paradigm: Contextual fear conditioning test using footshocks
 Fear conditioning test
 12-18 weeks
General locomotor activity1
 No change
 Home cage behavior
 14-22 weeks
Event related potential (erp) in electroencephalography (eeg)1
 No change
 Event related potential (erp)
 Unreported
Sensorimotor gating1
 No change
 Prepulse inhibition
 14-22 weeks
Startle response: acoustic stimulus1
 No change
 Acoustic startle reflex test
 14-22 weeks
Aggression1
 No change
 Three-chamber social approach test
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Maternal behavior, Molecular profile, Neuroanatomy / ultrastructure / cytoarchitecture, Physiological parameters, Repetitive behavior, Seizure


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
ATP7B ATPase, Cu++ transporting, beta polypeptide 540 B7ZLR4 IP; LC-MS/MS
Huttlin EL , et al. 2015
B3GNT2 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 10678 Q9NY97 IP; LC-MS/MS
Huttlin EL , et al. 2015
CALY calcyon neuron-specific vesicular protein 50632 Q9NYX4 IP/WB; Co-localization
Yin DM , et al. 2014
CISD2 CDGSH iron sulfur domain 2 NM_001008388 Q8N5K1 IP; LC-MS/MS
Huttlin EL , et al. 2015
CNTNAP3 contactin associated protein-like 3 79937 Q9BZ76 IP; LC-MS/MS
Huttlin EL , et al. 2015
DSE dermatan sulfate epimerase 29940 Q9UL01 IP; LC-MS/MS
Huttlin EL , et al. 2015
GALNT11 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11) 63917 B3KWF4 IP; LC-MS/MS
Huttlin EL , et al. 2015
GLMN glomulin, FKBP associated protein 11146 Q92990 IP; LC-MS/MS
Huttlin EL , et al. 2015
GYLTL1B Glycosyltransferase-like protein LARGE2 120071 Q8N3Y3 IP; LC-MS/MS
Huttlin EL , et al. 2015
HEATR2 HEAT repeat containing 2 54919 B3KPE2 IP; LC-MS/MS
Huttlin EL , et al. 2015
HLA-DPB1 major histocompatibility complex, class II, DP beta 1 3115 I4EC15 IP; LC-MS/MS
Huttlin EL , et al. 2015
HS6ST1 heparan sulfate 6-O-sulfotransferase 1 9394 O60243 IP; LC-MS/MS
Huttlin EL , et al. 2015
INTS7 integrator complex subunit 7 25896 Q9NVH2 IP; LC-MS/MS
Huttlin EL , et al. 2015
LEMD3 LEM domain containing 3 23592 Q9Y2U8 IP; LC-MS/MS
Huttlin EL , et al. 2015
LGR4 leucine-rich repeat containing G protein-coupled receptor 4 55366 Q59ER8 IP; LC-MS/MS
Huttlin EL , et al. 2015
LPHN1 latrophilin 1 22859 O94910 IP; LC-MS/MS
Huttlin EL , et al. 2015
LSR lipolysis stimulated lipoprotein receptor 51599 Q86X29 IP; LC-MS/MS
Huttlin EL , et al. 2015
MBOAT7 membrane bound O-acyltransferase domain containing 7 79143 Q96N66 IP; LC-MS/MS
Huttlin EL , et al. 2015
PGAP1 post-GPI attachment to proteins 1 80055 Q75T13 IP; LC-MS/MS
Huttlin EL , et al. 2015
POMT1 protein-O-mannosyltransferase 1 10585 Q9Y6A1 IP; LC-MS/MS
Huttlin EL , et al. 2015
RHOBTB3 Rho-related BTB domain containing 3 22836 O94955 IP; LC-MS/MS
Huttlin EL , et al. 2015
SFXN3 Sideroflexin-3 81855 Q9BWM7 IP; LC-MS/MS
Huttlin EL , et al. 2015
SLC22A18 Solute carrier family 22 member 18 5002 Q96BI1 IP; LC-MS/MS
Huttlin EL , et al. 2015
SLC25A16 solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16 8034 P16260 IP; LC-MS/MS
Huttlin EL , et al. 2015
SLC25A23 solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 79085 Q9BV35 IP; LC-MS/MS
Huttlin EL , et al. 2015
SLC35B2 solute carrier family 35, member B2 347734 Q8TB61 IP; LC-MS/MS
Huttlin EL , et al. 2015
SREBF2 sterol regulatory element binding transcription factor 2 6721 Q12772 IP; LC-MS/MS
Huttlin EL , et al. 2015
TM2D3 TM2 domain containing 3 80213 Q9BRN9 IP; LC-MS/MS
Huttlin EL , et al. 2015
TMEM164 transmembrane protein 164 84187 Q5U3C3 IP; LC-MS/MS
Huttlin EL , et al. 2015
TMEM39B transmembrane protein 39B 55116 Q9BT39 IP; LC-MS/MS
Huttlin EL , et al. 2015
TMEM63B transmembrane protein 63B 55362 Q5T3F8 IP; LC-MS/MS
Huttlin EL , et al. 2015
TMTC4 transmembrane and tetratricopeptide repeat containing 4 84899 Q5T4D3 IP; LC-MS/MS
Huttlin EL , et al. 2015
TUBB3 tubulin, beta 3 class III 10381 A8K854 IP; LC-MS/MS
Huttlin EL , et al. 2015
ZDHHC17 zinc finger, DHHC-type containing 17 23390 Q8IUH5 IP; LC-MS/MS
Huttlin EL , et al. 2015
Adam17 a disintegrin and metallopeptidase domain 17 11491 Q9Z0F8 IP/WB
Hartmann M , et al. 2015
Nrg1 neuregulin 1 211323 Q6DR98 bimolecular fluorescence complementation assay; IP/WB
Hartmann M , et al. 2015
Prkcd protein kinase C, delta 18753 P28867 IP/WB
Hartmann M , et al. 2015
BACE1 beta-site APP-cleaving enzyme 1 23621 P56817 in vivo secretase assay
Fleck D , et al. 2015
PSEN1 presenilin 1 5663 P49768 in vivo secretase assay
Fleck D , et al. 2015
SPPL2A signal peptide peptidase like 2A 84888 Q8TCT8 in vivo secretase assay
Fleck D , et al. 2015
SPPL2B signal peptide peptidase like 2B 56928 Q8TCT7 in vivo secretase assay
Fleck D , et al. 2015

HELP
Copyright © 2017 MindSpec, Inc.